Right to Registration. The Holder has the right to require the Company to register the Warrant Shares under the Act in accordance with the terms of an agreement (the “Registration Rights Agreement”) dated as of the date hereof between the Company and the Holders. The date on which the first Registration Statement filed pursuant to the Registration Rights Agreement is declared effective by the Commission is herein referred to as the “Effective Date.”
Right to Registration. In the event Exelixis elects to exercise the Purchase Option as set forth in the Purchase Option Agreement, and in so doing elects to issue Purchase Option Related Registrable Securities, Exelixis shall prepare and, in accordance with Section 2(a)(ii)(A) of the Purchase Option Agreement, file with the SEC a Registration Statement on Form S-3 covering the resale of the Purchase Option Related Registrable Securities. The Registration Statement prepared pursuant hereto shall register for resale that number of shares of Exelixis Common Stock equal to the number of Purchase Option Related Registrable Securities as would be issued pursuant to the terms of the Purchase Option Agreement. Exelixis shall use commercially reasonable efforts to have the Registration Statement declared effective by the SEC as soon as practicable following the Purchase Option Exercise Date.
Right to Registration. (i) Dynavax shall prepare and, as soon as practicable but in no event later than two (2) Business Days after the Purchase Option Closing Date and each Adjusted Securities Payment Date (as defined in the Purchase Option Agreement), file with the SEC a Registration Statement on Form S-3 covering the resale of the then unregistered Registrable Securities (except for any Promissory Note Securities). Each Registration Statement prepared pursuant hereto shall register for resale that number of shares of Dynavax Common Stock equal to (A) the number of the then unregistered Related Registrable Securities (except for any Promissory Note Securities) constituting Dynavax Common Stock, plus (B) the maximum number of shares of Dynavax Common Stock issuable upon the exercise, conversion or exchange (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment of such number) of the then unregistered Registrable Securities (other than the Registrable Securities constituting Dynavax Common Stock and any Promissory Note Securities), in each case, as of the trading day immediately preceding the date such Registration Statement is initially filed with the SEC, subject to adjustment as provided in Sections 2(c). Dynavax shall use commercially reasonable efforts to have each such Registration Statement declared effective by the SEC as soon as practicable following the Purchase Option Closing Date or Adjusted Securities Payment Date, as applicable.
Right to Registration a. The Optionee, upon written request at any time from the Grant Date through the Expiration Date, may make one demand requesting that the Company use its reasonable best efforts to effect the registration under the Securities Act of all or part of the Optioned Shares then held by the Optionee. Registration requested pursuant to this Section 10 shall be effected by the filing of a registration statement on the appropriate registration form, as determined by the Company.
Right to Registration. (a) In the event that the Corporation is unable to redeem the Series A Preferred Stock by the Mandatory Redemption Date (defined below), then the Corporation will seek to register the Series A Preferred Stock with the SEC to create a public market for the shares.
Right to Registration. The Holder has the right to require the Company to register the Warrant Shares pursuant to a registration statement (the “Registration Statement”) under the Securities Act of 1933 (the “Act”) with the Securities and Exchange Commission (the “Commission”) in accordance with the terms of an agreement (the “Registration Rights Agreement”) dated as of the date hereof among the Company, the Holder and the holders of other Class A Warrants. The date that the first Registration Statement filed pursuant to the Registration Rights Agreement is declared effective by the Commission is herein referred to as the “Effective Date.”
Right to Registration. (a) The Company shall file a registration statement on Form S-3 for the common stock that underlies the Note and Class C Warrants (collectively, the “Underlying Shares”) with the Securities and Exchange Commission (the “Commission”) within 90 days of the closing of the purchase of the Notes and use its reasonable best efforts to have such registration statement declared effective. The Company will also grant the Payee certain “piggyback” registration rights with respect to these securities.
Right to Registration. Pxxxx has the right to require Maker to register the resale of the Underlying Shares and the shares issuable upon exercise of the Warrants owned by Payee (the “Warrant Shares”) under the Act pursuant to a registration statement (a “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) in accordance with the terms of an agreement (the “Registration Rights Agreement”) dated as of the date hereof among Maker, Payee and the holders of the other Notes. The date that the first Registration Statement filed pursuant to the Registration Rights Agreement is declared effective by the Commission is herein referred to as the “Effective Date.” Appendix A-10 MateonTherapeutics, Inc.16% Convertible NotePage 11
Right to Registration. The Company shall use its reasonable best efforts to cause to be filed by December 31, 2008 a Shelf Registration Statement providing for the sale of all the Registrable Securities by the Investors and to have such Shelf Registration Statement declared effective by the SEC. The Company agrees to use its reasonable best efforts to keep the Shelf Registration Statement continuously effective until the Investors are eligible to sell any of their Registrable Securities under Rule 144.
Right to Registration. (a) On or after the date hereof, Shareholder shall have the right, exercisable upon written notice to RNET, to have the Shares included in any Registration Statement, containing therein a Prospectus, filed from time to time by RNET (other than a registration statement with respect to the resale of Financing Shares (as such term is defined in the Company's Prospectus dated September 29, 1997)), on such form as may then be required or available for use by RNET under the Securities Act to permit the public offering of shares of the Common Stock. Such request shall specify the number of Shares proposed to be subject to such Registration Statement. RNET shall use its best efforts, including the filing of any amendments or supplements thereto, to have any such Registration Statement declared effective under the Securities Act as soon as practicable after the filing date thereof. RNET shall also use its best efforts to keep any such Registration Statement and the accompanying Prospectus effective and current under the Securities Act at its expense for period of 90 days after its effective date. Notwithstanding the foregoing, the obligation of RNET under this Section 2(a) is subject to (i) the right of RNET or the managing underwriter, if any, to limit the number of Shares to be included in any registration hereunder if RNET or such underwriter determines in good faith that the offering of the requested number of Shares will adversely affect the market for the Common Stock and (ii) the provisions of Section 3. During the term of this Agreement, RNET shall not grant registration rights to any person that would allow such person to have "piggy-back" registration rights unless such rights specifically provide for Shareholder's shares of Common Stock to be included, at Shareholder's election, in the same registration statement as such person's shares and for any limitations to be imposed against such person's shares prior to limitations being imposed on Shareholders' shares.
